Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 261,595 | 235,173 | 206,111 | 178,101 | 149,548 |
| Cost of Goods | 42,100 | 37,018 | 33,832 | 34,634 | 32,562 |
| Gross Profit | 219,495 | 198,155 | 172,279 | 143,467 | 116,986 |
| Operating Expenses | 231,427 | 189,739 | 164,852 | 140,177 | 126,949 |
| Operating Income | -11,832 | 8,434 | 8,259 | 3,924 | -9,401 |
| Interest Expense | 0 | 58 | 205 | 0 | 62 |
| Other Income | -579 | 295 | 221 | 228 | 612 |
| Pre-tax Income | -12,411 | 8,671 | 8,275 | 4,152 | -8,851 |
| Income Tax | 346 | 422 | 429 | -136 | 560 |
| Net Income Continuous | -12,757 | 8,249 | 7,846 | 4,288 | -9,411 |
| Net Income | $-12,757 | $8,249 | $7,846 | $4,288 | $-9,411 |
| EPS Basic Total Ops | -0.42 | 0.27 | 0.27 | 0.15 | -0.33 |
| EPS Basic Continuous Ops | -0.42 | 0.27 | 0.27 | 0.15 | -0.33 |
| EPS Diluted Total Ops | -0.42 | 0.26 | 0.26 | 0.14 | -0.33 |
| EPS Diluted Continuous Ops | -0.42 | 0.26 | 0.26 | 0.14 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,508 | $13,905 | $15,569 | $11,104 | $-2,810 |